Fennec PharmaceuticalsvsEli Lilly and Company

FENC and LLY stock compared: price, dividend, valuation and results, from SEC filings.

FENC

Fennec Pharmaceuticals Inc.

$13.58

Value $468M

+6.43%
FENC's page

LLY

Eli Lilly and Company

$1,415.55

Value $1.34T

-1.13%
LLY's page

Fennec Pharmaceuticals (FENC) has a market value of $468M and Eli Lilly and Company (LLY) $1.34T. Over the last year, with dividends, FENC moved +72.8% and LLY +38.9%. The P/E is 333.3 for FENC and 48.4 for LLY. Dividend yield: FENC none, LLY 0.45%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FENC$468M

    LLY$1.34T

    LLY is 2,852 times FENC

  • Revenue, 12 months

    FENC$66M

    LLY$86.5B

    LLY is 1,303 times FENC

  • Net income, 12 months

    FENC$2.0M

    LLY$27.6B

    LLY is 13,599 times FENC

  • Operating margin

    FENC5.6%

    LLY–

  • ROIC

    FENC–

    LLY35.5%

  • P/E

    FENC333.3

    LLY48.4

    FENC is 6.9 times LLY

  • Dividend yield

    FENC0.0%

    LLY0.4%

    0.5 points apart

  • 5-year return

    FENC+39.9%

    LLY+473.5%

    433.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FENC+39.9%

LLY+473.5%

20040060020222023202420252026
Returns by period
PeriodFENCWith dividendsLLYWith dividends
1 year since November 14, 2025+72.8%Price +72.8%+38.9%Price +38.1%
3 years since November 17, 2023+63.2%+17.7% a yearPrice +63.2%+144.0%+34.6% a yearPrice +139.2%
5 years since November 16, 2021+39.9%+6.9% a yearPrice +39.9%+473.5%+41.8% a yearPrice +449.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FENCFennec PharmaceuticalsLLYEli Lilly and Company

Valuation

FENCLLY
Valuation
Price$13.58$1,415.55
Market value$468M$1.34T
Enterprise value (EV)–$1.38T
P/E333.348.4
P/E, 5-year median–49.9
P/B9.533.2
EV/EBIT–39.7
Free cash flow yield0.7%1.5%

Results and growth

FENCLLY
Results and growth
Revenue, 12 months$66M$86.5B
Net income, 12 months$2.0M$27.6B
Free cash flow, 12 months$3.1M$19.7B
Earnings per share, 12 months$0.04$30.81
Revenue growth, year on year-6.1%44.7%
Revenue growth a year, past+204.7%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

FENCLLY
Margins and returns on capital
Gross margin–83.6%
Operating margin5.6%–
Net margin3.1%31.9%
ROIC–35.5%
ROE6.3%88.6%

Balance sheet

FENCLLY
Balance sheet
Cash$49M$4.9B
Total debt–$49.5B
Net debt / EBITDA–1.2
Interest cover11.7×38.9×

Dividends and buybacks

FENCLLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield–0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FENC or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Fennec Pharmaceuticals or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.34T) is about 2,852.3 times Fennec Pharmaceuticals ($468M), at today's prices.

How did FENC and LLY stock do over the last 5 years?

Since November 16, 2021, FENC's price moved +39.9% and LLY's +449.3%. With dividends: FENC +39.9% (+6.9% a year), LLY +473.5% (+41.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, FENC or LLY?

The dividend yield at today's price is none for Fennec Pharmaceuticals and 0.45% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of FENC and LLY?

At today's price, the P/E is 333.3 for FENC and 48.4 for LLY. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Fennec Pharmaceuticals or Eli Lilly and Company?

Over the last twelve months, the net margin was 3.1% for Fennec Pharmaceuticals and 31.9% for Eli Lilly and Company, and the operating margin 5.6% and –. Revenue was $66M and $86.5B.

Which is the better investment, Fennec Pharmaceuticals or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.